Print this page
Sarcoma
-
Novel Immune Checkpoint Expression on Circulating Tumor Cells of Sarcomas.
Protocol: 112103Principal Investigator:
-
Scott A Moerdler
Applicable Disease Sites: Soft Tissue -
A Phase 3 Randomized Controlled Trial Comparing Open vs Thoracoscopic Management of Pulmonary Metastases in Patients with Osteosarcoma.
Protocol: 112201Principal Investigator:
-
Scott A Moerdler
Applicable Disease Sites: Bones and Joints
Lung -
Pediatric Acute Leukemia (PedAL) Screening Trial: Developing New Therapies for Relapsed Leukemias.
Protocol: 112204Principal Investigator:
-
Richard A Drachtman
Applicable Disease Sites: Leukemia, not otherwise specified -
A Prospective Phase 3 Study of Patients with Newly Diagnosed Very Low-risk and Low-risk Fusion Negative Rhabdomyosarcoma.
Protocol: 112205Principal Investigator:
-
Scott A Moerdler
Applicable Disease Sites: Soft Tissue -
A Phase 1, Multicenter, Open-Label, 2-Stage, Single-Arm Study to Evaluate the Safety and Tolerability of an Autologous Tumor-Infiltrating Lymphocytes (TIL) Regimen and Preliminary Antitumor Activity of TIL in Pediatric, Adolescent, and Young Adult Participants with Relapsed or Refractory Solid Tumors.
Protocol: 112309Applicable Disease Sites: Any Site
-
LIGHTBEAM-U01 Substudy 01A: A Phase 1/2 Substudy to Evaluate the
Safety and Efficacy of Zilovertamab Vedotin in Pediatric and Young Adult Participants With
Hematologic Malignancies or Solid Tumors
Protocol: 112401Principal Investigator:
-
Richard A Drachtman
Applicable Disease Sites: Any Site -
Web-Based Coping and Communication Skills Intervention for Women who are newly diagnosed with Gynecological Cancer: A Pilot Study.
Protocol: 131908Principal Investigator:
-
Sharon Manne
Applicable Disease Sites: Cervix
Ovary -
Phase III Trial of Lomustine-Temozolomide Combination Therapy Versus Standard Temozolomide in Patients with Methylated MGMT Promoter Glioblastoma.
Protocol: 142202Applicable Disease Sites: Brain and Nervous System
- 1
- 2